Renal cell carcinoma and malignant peritoneal mesothelioma after occupational asbestos exposure: case report. Candura SM, Boeri R, Teragni C, Chen Y, Scafa F. Med Lav. 2016 May 26;107(3):172-7.
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life. Palumbo R, Sottotetti F, Trifirò G, Piazza E, Ferzi A, Gambaro A, Spinapolice EG, Pozzi E, Tagliaferri B, Teragni C, Bernardo A. Drug Des Devel Ther. 2015 Apr 15;9:2189-99.
Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians. Palumbo R, Sottotetti F, Riccardi A, Teragni C, Pozzi E, Quaquarini E, Tagliaferri B, Bernardo A. Ther Adv Med Oncol. 2013 Nov;5(6):334-50.
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. Strada MR, Palumbo R, Bernardo A, Riccardi A, Teragni C, Poggi G, Frascaroli M, Amatu A, Montagna B, Sottotetti F, Tagliaferri B, Bernardo G. Clin Breast Cancer. 2012 Feb;12(1):30-9.
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Agnelli G, Gussoni G, Bianchini C, Verso M, Mandalà M, Cavanna L, Barni S, Labianca R, Buzzi F, Scambia G, Passalacqua R, Ricci S, Gasparini G, Lorusso V, Bonizzoni E, Tonato M; PROTECHT Investigators. Lancet Oncol. 2009 Oct;10(10):943-9.
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors. Poggi G, Quaretti P, Minoia C, Bernardo G, Bonora MR, Gaggeri R, Ronchi A, Saluzzo CM, Azzaretti A, Rodolico G, Montagna M, Amatu A, Teragni C, Palumbo I, Traverso E, Tonini S, Villani L, Scelsi M, Baiardi P, Felisi MG, Sottotetti F, Tagliaferri B, Riccardi A. Anticancer Res. 2008 Nov-Dec;28(6B):3835-42
Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report. Poggi G, Quaretti P, Minoia C, Palumbo I, Villani L, Amatu A, Teragni C, Scelsi M, Zappoli F, Bernardo G. Anticancer Res. 2008 Sep-Oct;28(5B):2987-90.
Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation. Sottani C, Rinaldi P, Leoni E, Poggi G, Teragni C, Delmonte A, Minoia C. Rapid Commun Mass Spectrom. 2008 Sep;22(17):2645-59.
Complications of percutaneous radiofrequency thermal ablation of primary and secondary lesions of the liver. Poggi G, Riccardi A, Quaretti P, Teragni C, Delmonte A, Amatu A, Saini G, Mazzucco M, Bernardo A, Palumbo R, Canto A, Bernieri S, Bernardo G. Anticancer Res. 2007 Jul-Aug; 27(4C):2911-6.
